论文部分内容阅读
目的分析2型糖尿病合并高血压患者降血压药物使用情况。方法选取2014年某院住院的2型糖尿病合并高血压患者300例,记录患者出院时降压药物使用情况、联合用药情况。结果 2014年某院降压药物种类主要包括钙通道阻滞剂(CCB)、血管紧张素转化酶抑制剂(ACEI)、血管紧张素Ⅱ受体阻滞剂(ARB)、β受体阻滞剂(β-B)、利尿剂和复方制剂,其中CCB的使用频次最多,占31.3%;其次为ACEI,占21.5%。2014年某院降压药物使用中二联用药最多,共132次(44.0%),其中CCB+ACEI最常见,共65次(21.7%);三联用药中CCB+ACEI+β-B共22次(7.3%);四联用药中CCB+ACEI+β-B+利尿剂共18次(6.0%)。结论 2型糖尿病合并高血压患者选择降压药物时,医生必须严格掌握药物禁忌证、适应证及患者的具体情况,为患者提供安全有效、使用方便、价格合理、可持续治疗的方案。
Objective To analyze the use of antihypertensive drugs in type 2 diabetic patients with hypertension. Methods 300 patients with type 2 diabetes mellitus and hypertension were hospitalized in a hospital in 2014. The usage of antihypertensive drugs and drug combination were recorded at discharge. Results The types of antihypertensive drugs in a hospital in 2014 mainly included calcium channel blockers (CCBs), angiotensin converting enzyme inhibitors (ACEIs), angiotensin Ⅱ receptor blockers (ARBs), β-blockers (β-B), diuretics and compound preparations, of which CCB was the most frequently used, accounting for 31.3%; followed by ACEI, accounting for 21.5%. In 2014, the use of antihypertensive drugs in a hospital was the most commonly used in two groups, with a total of 132 (44.0%) cases, of which CCB + ACEI was the most common, 65 times (21.7%); CCB + ACEI + (7.3%); CCB + ACEI + β-B + diuretic in quadruple drug treatment was 18 times (6.0%). Conclusions When selecting antihypertensive drugs for patients with type 2 diabetes mellitus and hypertension, doctors must strictly control drug contraindications, indications and patients’ specific conditions so as to provide patients with safe, effective, convenient, affordable and sustainable treatment programs.